全文获取类型
收费全文 | 4324篇 |
免费 | 296篇 |
国内免费 | 39篇 |
专业分类
耳鼻咽喉 | 44篇 |
儿科学 | 92篇 |
妇产科学 | 78篇 |
基础医学 | 594篇 |
口腔科学 | 78篇 |
临床医学 | 402篇 |
内科学 | 991篇 |
皮肤病学 | 94篇 |
神经病学 | 296篇 |
特种医学 | 132篇 |
外科学 | 567篇 |
综合类 | 75篇 |
一般理论 | 2篇 |
预防医学 | 343篇 |
眼科学 | 279篇 |
药学 | 303篇 |
中国医学 | 33篇 |
肿瘤学 | 256篇 |
出版年
2024年 | 11篇 |
2023年 | 56篇 |
2022年 | 130篇 |
2021年 | 211篇 |
2020年 | 157篇 |
2019年 | 196篇 |
2018年 | 237篇 |
2017年 | 158篇 |
2016年 | 180篇 |
2015年 | 167篇 |
2014年 | 201篇 |
2013年 | 273篇 |
2012年 | 389篇 |
2011年 | 381篇 |
2010年 | 229篇 |
2009年 | 184篇 |
2008年 | 266篇 |
2007年 | 259篇 |
2006年 | 204篇 |
2005年 | 142篇 |
2004年 | 134篇 |
2003年 | 110篇 |
2002年 | 71篇 |
2001年 | 24篇 |
2000年 | 25篇 |
1999年 | 19篇 |
1998年 | 15篇 |
1997年 | 10篇 |
1996年 | 15篇 |
1995年 | 11篇 |
1994年 | 9篇 |
1993年 | 9篇 |
1992年 | 6篇 |
1991年 | 10篇 |
1990年 | 15篇 |
1989年 | 7篇 |
1988年 | 6篇 |
1987年 | 6篇 |
1985年 | 7篇 |
1984年 | 8篇 |
1983年 | 6篇 |
1982年 | 8篇 |
1981年 | 6篇 |
1980年 | 8篇 |
1979年 | 11篇 |
1978年 | 8篇 |
1977年 | 11篇 |
1974年 | 7篇 |
1973年 | 7篇 |
1971年 | 8篇 |
排序方式: 共有4659条查询结果,搜索用时 15 毫秒
41.
42.
43.
Liver dysfunction in Pennsylvania's multitransfused hemophiliacs 总被引:1,自引:0,他引:1
Dr. Ute Hasiba MD M. Elaine Eyster MD Frances M. Gill MD Mehdi Kajani MD Jessica H. Lewis MD Charles J. Lusch MD David Prager MD Samuel A. Rice MD Sandor S. Shapiro MD 《Digestive diseases and sciences》1980,25(10):776-782
Transaminase values [alanine amino transferase (ALT) and aspartate amino transferase (AST)] and markers for hepatitis B were serially determined in 558 hemophiliacs exposed to blood products. Hepatitis B surface antigen (HBsAg) persistent for over 12 months was present in 6% of the patients. Antibody to hepatitis B surface antigen (anti-HBs) was noted in 90% of the 259 patients treated with factor VIII or IX concentrates but in only 49% of the 43 patients treated with fresh frozen plasma (FFP) or cryoprecipitate. Persistently abnormal transaminase values were noted in 31% of the patients treated with commercial concentrates but in only one (2%) of the patients exposed to cryoprecipitate or FFP. This difference continued even when the two groups of patients were matched for the amount of blood products, up to 50, 000 units, which they had received in the study period. In the concentrate-treated patients, no correlation could be found between transaminase values and the number of units of factor VIII or IX they had received during the six years of the study (1973–1978).Supported in part by the Pennsylvania Hemophilia Centers and the Pennsylvania State-Wide Hemophilia Program. 相似文献
44.
45.
46.
47.
Ghorbani Maedeh Mohamadynejad Parisa Moghanibashi Mehdi 《Metabolic brain disease》2022,37(4):1025-1030
Metabolic Brain Disease - Multiple sclerosis (MS) is a chronic inflammatory and autoimmune disease characterized by demyelination of the central nervous system (CNS). Neuregulin 1 (NRG1) is a... 相似文献
48.
Jean Bousquet Toni Dedeu Eve Dupas Jean-Louis Pépin Landry Stephane Zeng Eyindanga Sylvie Arnavielhe Julia Ayache Xavier Basagana Samuel Benveniste Nuria Calves Venturos Hing Kin Chan Mehdi Cheraitia Yves Dauvilliers Judith Garcia-Aymerich Ingrid Jullian-Desayes Chitra Dinesh Daniel Laune Jade Lu Dac Ismael Nujurally Giovanni Pau Robert Picard Xavier Rodo Renaud Tamisier Michael Bewick Nils E. Billo Wienczyslawa Czarlewski Joao Fonseca Ludger Klimek Oliver Pfaar Jean-Marc Bourez 《Clinical and translational allergy》2018,8(1):36
Allergic rhinitis (AR) is impacted by allergens and air pollution but interactions between air pollution, sleep and allergic diseases are insufficiently understood. POLLAR (Impact of air POLLution on sleep, Asthma and Rhinitis) is a project of the European Institute of Innovation and Technology (EIT Health). It will use a freely-existing application for AR monitoring that has been tested in 23 countries (the Allergy Diary, iOS and Android, 17,000 users, TLR8). The Allergy Diary will be combined with a new tool allowing queries on allergen, pollen (TLR2), sleep quality and disorders (TRL2) as well as existing longitudinal and geolocalized pollution data. Machine learning will be used to assess the relationship between air pollution, sleep and AR comparing polluted and non-polluted areas in 6 EU countries. Data generated in 2018 will be confirmed in 2019 and extended by the individual prospective assessment of pollution (portable sensor, TLR7) in AR. Sleep apnea patients will be used as a demonstrator of sleep disorder that can be modulated in terms of symptoms and severity by air pollution and AR. The geographic information system GIS will map the results. Consequences on quality of life (EQ-5D), asthma, school, work and sleep will be monitored and disseminated towards the population. The impacts of POLLAR will be (1) to propose novel care pathways integrating pollution, sleep and patients’ literacy, (2) to study sleep consequences of pollution and its impact on frequent chronic diseases, (3) to improve work productivity, (4) to propose the basis for a sentinel network at the EU level for pollution and allergy, (5) to assess the societal implications of the interaction. MASK paper N°32. 相似文献
49.
Purpose
The evidence has suggested that resveratrol has anti-inflammatory effect; however, the results are inconsistent and inconclusive. The aim of this study was to assess the effect of resveratrol supplementation on the levels of inflammatory markers through a systematic review and meta-analysis of available randomized controlled trials (RCTs).Methods
A search strategy was completed using Medline, ISI Web of Science, Directory of Open Access Journal, SID, ProQuest, Cochrane Library, Scopus, and EMBASE up to May 2017, to identify placebo-controlled RCTs that assessed resveratrol effects on circulating (serum and plasma) inflammatory markers (interleukin [IL]-6, tumor necrosis factor–α [TNF-α], and high-sensitivity C-reactive protein [hs-CRP]) among adult participants aged 17 years and older in 17 RCTs with a total of 736 subjects. The evaluation of study quality was performed using the Jadad scale. Weighted mean difference (WMD) was calculated for evaluating the changes in the inflammatory markers using fixed-effects or random-effects models. We performed subgroup and sensitivity analyses to evaluate the heterogeneity of the studies.Findings
Seventeen RCTs, including 736 subjects, fulfilled the eligibility criteria and were selected for analyses. The results of meta-analysis found significant reductions in the level of TNF-α (WMD, –0.44; 95% CI, –0.71 to –0.164; P?=?0.002; Q statistic?=?21.60; I2?=?49.1%; P?=?0.02) and hs-CRP (WMD, –0.27; 95% CI, –0.5 to –0.02; P?=?0.033; Q statistic?=?26.95; I2?=?51.8%; P?=?0.013) after supplementation with resveratrol. Resveratrol supplementation had no significant effect on the level of IL-6 (WMD, –0.16; 95% CI, –0.53 to 0.20; P?=?0.38; Q statistic?=?36.0; I2?=?72.3%; P?=?0.001). Statistically significant heterogeneity was observed for the type of sample in IL-6 and study duration in inflammatory markers IL-6, TNF-α, and hs-CRP.Implications
Available evidence from RCTs suggests that resveratrol supplementation significantly reduced TNF-α and hs-CRP levels. Significant improvement in inflammatory markers support resveratrol as an adjunct to pharmacologic management of metabolic diseases. 相似文献50.
Mitra Samareh Fekri Mehdi Torabi Sara Azizi Shoul Moghaddameh Mirzaee 《The American journal of emergency medicine》2018,36(2):277-280